Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional epidemiological cut-off values for Mycobacterium tuberculosis complex
- PMID: 37147011
- DOI: 10.1183/13993003.02397-2022
Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional epidemiological cut-off values for Mycobacterium tuberculosis complex
Conflict of interest statement
Conflicts of interest: C.U. Köser is a consultant for Becton Dickinson, the Foundation for Innovative New Diagnostics, the TB Alliance, and the WHO Global TB Programme; C.U. Köser's consulting for Becton Dickinson involves a collaboration with Janssen and Thermo Fisher Scientific; C.U. Köser is collaborating with PZA Innovation and is an unpaid advisor to GenoScreen; has worked as a consultant for QuantuMDx, the Stop TB Partnership, and the WHO Regional Office for Europe; has given a paid educational talk for Oxford Immunotec; and has been an unpaid advisor to BioVersys and Cepheid. Hain Lifescience covered C.U. Köser's travel and accommodation to present at a meeting. F.P. Maurer is an employee of Roche Diagnostics International Ltd, Rotkreuz, Switzerland.
Comment on
-
Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis.Eur Respir J. 2022 Oct 13;60(4):2200239. doi: 10.1183/13993003.00239-2022. Print 2022 Oct. Eur Respir J. 2022. PMID: 35301246 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical